-
Trump Threatens Heavy Taxes on US Firms Building Data Centers Abroad
-
Kuwait DGCA Delegation Attends ICAO Assembly in Montreal
-
Gozo Minister Clint Camilleri Appointed CPMR Vice-President for Maritime Affairs
-
Charlie Puth and Ellie Goulding to Headline First Johnnie & Co. Festival in Mumbai
-
ALIX LASERS shareholders remove Michael Sobitsch as managing director in view of the circumstances
-
Maryland Woman Arrested in Decade-Long Cancer Scam Involving Fake Medical Team
-
Panthers Seek NFC South Lead Against Ravens as Baltimore Ends Skid
-
Closing a Business with Payroll Taxes Owed - Clear Start Tax Explains the Trust Fund Recovery Penalty
-
Ondas, Palantir and Regna AI Host Key Defense Technology Leaders to Accelerate the Path from AI Innovation to Fielded Capability
-
Dateline appoints Tony Ferguson as Acting Chairman
-
American Businessman Mark Eric Williams Vindicated in Six-Year, US$150 Million-Plus Litigation Brought by Kuwaiti State Entities
-
AI Search Engineers Says Longer AI Mode Questions Mean Professional Service Firms Should Answer Full Client Questions Directly on Their Pages
-
Arrive AI's Pro Forma Stockholders' Equity Now Above Nasdaq Minimum Requirement Following Recent Transactions
-
Who Does the Best Rhinoplasty in Sarasota?
-
PodcastOne (NASDAQ:PODC) Launches People Pleasers Podcast hosted by Comedians Leah Rudick and Jessica Michelle Singleton
-
Alset AI Closes Non-Brokered Private Placement Offering
-
Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
-
barq Signs MoU with TenPay Global to Enhance Remittances and Digital Payments in China
-
American Resources Corporation and ReElement Technologies Selected as Part of Winning U.S.-Led Consortium for Kenya's Strategic Mrima Hill Critical Minerals Project
-
Ryde Group Ltd Announces Non-Binding Term Sheet for Proposed Minority Investment in Multi Genius Limited and MOU on Technology Collaboration
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 20
-
Tosca's 2026 Sustainability Report Makes the Case for Packaging as Critical Supply Chain Infrastructure
-
The DEA Laid The Trap - And State Marijuana Operators Took The Bait
-
5 Fun Date Night Ideas That Don't Cost a Fortune
-
Cytta Air Expands Military Contracting Expertise - Appoints Rear Admiral James "Gib" Godwin III to Advisory Board
-
APEX FTE Expo 2026 Unites Aviation Leaders in Singapore and Honors Passenger Experience Excellence
-
APEX Honors Aeroméxico CEO Dr. Andrés Conesa with Historic APEX CEO Lifetime Achievement Award
-
Enmarket to Open Newest Eatery Location in Rincon, GA
-
Eylsia Nicolas Hits No. 1 on Groover's Global and US Singer-Songwriter Charts with "One More Moment," as Taglish Preview of "Wake Me Up for Christmas" Passes One Million Views in Under 24 Hours
-
What Is the Best Social Media Platform for Peptides?
-
WhalesBot Advances Creativity-Driven AI and Coding Education Through Pubbo AI
-
Karviva Introduces Unwined Alcohol-Free Malbec and Rose Varieties
-
Tidal Wave Auto Spa Opens New Locations in Murfreesboro, Tennessee and Asheville, North Carolina This Week
-
Peoples Bancorp Announces Cash Dividend
-
Jaguar Health, Inc. Announces Reverse Stock Split
-
Kartoon Studios' Beacon Media Partners With Bandai on Tamagotchi's Landmark 30th Anniversary Times Square Celebration
-
First Phosphate and Zeo Energy Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
enVVeno Medical Presents Three-Year Surgical Venous Valve Replacement Data Showing Sustained Clinical Benefit and Highlights Next-Generation enVVe Transcatheter System at the 53rd Annual VEITH Symposium
-
Taylor Bank Announces $125,000 Commitment to Diakonia's Supportive Living Campus Capital Campaign
-
AsiaFIN Holdings Corp. Appoints Fortune Angel INC as U.S. Reseller Partner to Expand Its Agentic and Robotic Process Automation SaaS Business Across New York and the East Coast
-
Commonhold Explained: How New Leasehold Ban Changes Property Ownership in England and Wales
-
Factory Worker Dies in Rare Rectal Explosion Incident in Czechia
-
GIRLBAND! Headline Show at Rough Trade Marks National Breakthrough
EXPOSÉ: DEA's Marijuana Licensing Scheme Exposed - MMJ BioPharma's Case Reveals DEA Contradiction Blocking FDA Approved Cannabis Medicine
WASHINGTON, D.C. / ACCESS Newswire / October 26, 2025 / A recently disclosed memorandum of understanding between the DEA and a registered marijuana cultivator has revealed the DEA fatal flaw at the heart of America's cannabis research policy - one that proves MMJ BioPharma Cultivation's case and exposes why legitimate science has been paralyzed for nearly a decade.
The Bureaucratic Catch-22

Under the terms of the DEA's own memorandum, licensees are required to perform highly restricted tasks: apply for quotas, send samples to DEA approved labs, provide advance harvest notices, follow DEA mandated packaging and storage procedures, and ultimately invoice the DEA for the very cannabis they grow.
At the same time, the DEA mandates that applicants - including MMJ BioPharma Cultivation - must first present a "bona fide supply agreement" with an authorized buyer before the agency will issue a bulk manufacturing registration.
The problem?
"The DEA's own paperwork confirms exactly what we've told Congress and the courts," said Duane Boise, President & CEO of MMJ International Holdings.
"You cannot have a bona fide supply agreement without a manufacturing registration. Forcing that condition first isn't just bureaucratic error - it's regulatory entrapment that blocks lawful science."
A System Designed to Fail
MMJ BioPharma Cultivation has spent over seven years seeking DEA authorization to produce pharmaceutical-grade cannabis for its FDA-approved clinical trials in Huntington's disease and multiple sclerosis. Despite passing multiple inspections and earning two Orphan Drug Designations, the company remains stalled while less-qualified entities either sit dormant or operate under restrictive DEA MOUs that prohibit normal commerce.
The DEA's structure - inherited from the discredited University of Mississippi monopoly - keeps federal control over every gram of cannabis produced, turning manufacturers into government subcontractors rather than true pharmaceutical suppliers. This model violates both Congress's intent under the Controlled Substances Act and the FDA's scientific authority over drug manufacturing and safety.
Constitutional Implications
The Department of Justice's recent concession that DEA administrative law judges were unconstitutionally insulated from removal only strengthens MMJ's argument: the agency's in-house licensing system operates outside constitutional bounds and denies applicants basic due-process rights.
"The DEA has been playing regulator, prosecutor, and market participant all at once," Boise added. "That's not regulation - it's obstruction in uniform. And every day of delay means another day patients go without medicine the FDA has already cleared for human trials."
A Call for Congressional and Administrative Reform
MMJ BioPharma Cultivation is urging President Trump and DEA Administrator Terry Cole to end this paradox by issuing bulk manufacturing registrations before requiring supply agreements, aligning DEA procedure with federal law and FDA science.
Without that correction, no U.S. company can legally or commercially produce pharmaceutical grade cannabis - ensuring that innovation, jobs, and patient access will continue to migrate overseas.
About MMJ BioPharma Cultivation
MMJ BioPharma Cultivation Inc., a subsidiary of MMJ International Holdings Inc., develops pharmaceutical grade cannabis medicines for FDA-approved clinical trials targeting Huntington's disease and Multiple Sclerosis. Its parent company and affiliates, MMJ BioPharma Labs, operate within FDA and GMP compliance standards to pioneer the next generation of cannabinoid based therapeutics.
MMJ is represented by attorney Megan Sheehan.
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ BioPharma Cultivation
View the original press release on ACCESS Newswire
H.Romero--AT